Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-10.89%
↓ 101% below average
Average (18q)
978.58%
Historical baseline
Range
High:14000.00%
Low:-100.00%
Volatility
1440.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -10.89% |
| Q2 2025 | 230.47% |
| Q1 2025 | 4230.38% |
| Q4 2024 | -98.85% |
| Q3 2024 | -19.83% |
| Q2 2024 | 14000.00% |
| Q1 2024 | -66.87% |
| Q4 2023 | -84.39% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | 0.59% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | 458.54% |
| Q1 2022 | 153.82% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |